Skip to content
Recruiting

Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes

About this study

This study is a prospective, single-center clinical trial. It aims to establish an improved robotic-assisted radical prostatectomy for treating locally advanced prostate cancer. The technique evaluates the impact of preserving the anterior peritoneum of the bladder on postoperative bladder descent and urinary control recovery. A retrospective analysis compares this modified approach with traditional anterior approach surgery, assessing differences in oncological outcomes, early functional recovery, and postoperative complication rates. The goal is to provide new theoretical foundations and technical support for the prevention and treatment of postoperative urinary incontinence.

Condition
Robotic-Assisted Radical Prostatectomy, Locally Advanced Prostate Cancer, Bladder Suspension
Tested
conventional Robotic-assisted radical prostatectomy group, Improved Robotic-assisted radical prostatectomy group
Sponsor
First Affiliated Hospital of Fujian Medical University

Who can join

Age
Not specified
Sex
Male only
Healthy volunteers
Not accepted

Inclusion 7

  • Eligible sex: Male
  • Study condition: Robotic-Assisted Radical Prostatectomy, Locally Advanced Prostate Cancer, Bladder Suspension
  • prostate biopsy and clinical confirmation of high-risk prostate cancer (PSA \> 20 ng/mL, Gleason score ≥ 8, or cT stage ≥ T2c) followed by robotic-assisted radical prostatectomy
  • multiparametric MRI (mpMRI) with a 3.0 T scanner for prostate or pelvic scans performed within 30 days before the operation at our center
  • Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1
  • Complete clinical and prostate biopsy pathological data.
  • General health is good, with no infections, autoimmune diseases, hematologic disorders, or other malignancies.

Exclusion 2

  • Presence of surgical contraindications.
  • refusal of enhanced mpMRI imaging.

Where

1 site, 1 recruiting

first hospital affiliated of Fujian medical university

Fuzhou, Fujian, China

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.